Cargando…

BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists

BACKGROUND: The prognosis of B-cell acute lymphoblastic leukemia (B-ALL) has improved significantly with current first-line therapy, although the recurrence of B-ALL is still a problem. Toll-like receptor 9 (TLR9) agonists have shown good safety and efficiency as immune adjuvants. Apart from their i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Ling, Zhou, Lei, Han, Wei, Chen, Jingtao, Gu, Xiaoyi, Hu, Zheng, Yang, Yongguang, Li, Wei, Zhang, Xiaoying, Niu, Chao, Chen, Yongchong, Li, Hui, Cui, Jiuwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921080/ https://www.ncbi.nlm.nih.gov/pubmed/36765389 http://dx.doi.org/10.1186/s12967-023-03969-z

Ejemplares similares

Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression
por: Niu, Chao, et al.
Publicado: (2018)

Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application
por: Bai, Ling, et al.
Publicado: (2017)

NK Cell Subpopulation Is Altered and the Expression of TLR1 and TLR9 Is Decreased in Patients with Acute Lymphoblastic Leukemia
por: Sánchez-Herrera, David, et al.
Publicado: (2021)

MYC in T-cell acute lymphoblastic leukemia: functional implications and targeted strategies
por: Li, Qilong, et al.
Publicado: (2021)

Novel UHRF1-MYC Axis in Acute Lymphoblastic Leukemia
por: Park, Soyoung, et al.
Publicado: (2022)

A Dual TLR7/TLR9 Inhibitor HJ901 Inhibits ABC-DLBCL Expressing the MyD88 L265P Mutation
por: An, Beiying, et al.
Publicado: (2020)

Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma
por: Deng, Shuanglin, et al.
Publicado: (2014)

Small Molecule Bax Agonists for Cancer Therapy
por: Xin, Meiguo, et al.
Publicado: (2014)

Therapeutic Targeting of c-Myc in T-Cell Acute Lymphoblastic Leukemia (T-ALL)
por: Loosveld, Marie, et al.
Publicado: (2014)

Synergy of purine-scaffold TLR7 agonist with doxorubicin on systemic inhibition of lymphoma in mouse model
por: Gao, Dong, et al.
Publicado: (2017)

The acute lymphoblastic leukemia prognostic scoring whether it is possible by BCL-2, BAX gene promoter genotyping
por: Moazami-Goudarzi, Mozhagan, et al.
Publicado: (2016)

Antigen Complexed with a TLR9 Agonist Bolsters c-Myc and mTORC1 Activity in Germinal Center B Lymphocytes
por: Wigton, Eric J., et al.
Publicado: (2019)

Comparison of human B cell activation by TLR7 and TLR9 agonists
por: Hanten, John A, et al.
Publicado: (2008)

PD-1-positive Natural Killer Cells have a weaker antitumor function than that of PD-1-negative Natural Killer Cells in Lung Cancer
por: Niu, Chao, et al.
Publicado: (2020)

Enhanced levels of the apoptotic BAX/BCL-2 ratio in children with acute lymphoblastic leukemia and high-risk features
por: Kaparou, Maria, et al.
Publicado: (2013)

BAK/BAX-Mediated Apoptosis Is a Myc-Induced Roadblock to Reprogramming
por: Kim, Esther J.Y., et al.
Publicado: (2018)

Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice
por: Jamerson, M H, et al.
Publicado: (2004)

Relationship between Bax and Bcl-2 Protein Expression and Outcome of Induction Phase Chemotherapy in Pediatric Acute Lymphoblastic Leukemia
por: Cahyadi, Andi, et al.
Publicado: (2022)

TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism
por: Noack, J, et al.
Publicado: (2012)

Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia
por: Oliveira, Mariana L., et al.
Publicado: (2022)

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma
por: Zhou, Zhimei, et al.
Publicado: (2021)

Non-Coated Rituximab Induces Highly Cytotoxic Natural Killer Cells From Peripheral Blood Mononuclear Cells via Autologous B Cells
por: Niu, Chao, et al.
Publicado: (2021)

LncRNA NCAL1 potentiates natural killer cell cytotoxicity through the Gab2-PI3K-AKT pathway
por: Niu, Chao, et al.
Publicado: (2022)

BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes
por: Wu, Shuiyan, et al.
Publicado: (2021)

Zebrafish MYC-induced leukemia models: unique in vivo systems to study B and T cell acute lymphoblastic leukemia
por: Borga, Chiara, et al.
Publicado: (2019)

TLR3 and TLR9 Agonists Improve Postexposure Vaccination Efficacy of Live Smallpox Vaccines
por: Israely, Tomer, et al.
Publicado: (2014)

Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant
por: Wei, Jingjing, et al.
Publicado: (2022)

pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG
por: Wu, Jing, et al.
Publicado: (2019)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
por: Shen, Kuan-Yin, et al.
Publicado: (2020)

Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity
por: Younes, Ahmed I., et al.
Publicado: (2020)

Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
por: Cascini, Caterina, et al.
Publicado: (2023)

Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists
por: Lacerte, Patricia, et al.
Publicado: (2016)

Microbial TLR Agonists and Humoral Immunopathogenesis in HIV Disease
por: Yu, Xiaocong, et al.
Publicado: (2013)

Prediction of novel mouse TLR9 agonists using a random forest approach
por: Khanna, Varun, et al.
Publicado: (2019)

Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia
por: Gutierrez, Alejandro, et al.
Publicado: (2011)

Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia
por: Reynolds, Christine, et al.
Publicado: (2014)

Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis
por: Borga, Chiara, et al.
Publicado: (2018)

Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement
por: Bomken, Simon, et al.
Publicado: (2022)

Conjugation of TLR7 Agonist Combined with Demethylation Treatment Improves Whole-Cell Tumor Vaccine Potency in Acute Myeloid Leukemia
por: Zhong, Guocheng, et al.
Publicado: (2020)

P392: FEATURES AND TREATMENT OF PATIENTS WITH T(8;14)(Q24;Q11)/ TCRA/D::MYC TRANSLOCATED T ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA (T-ALL/LBL)
por: Zhang, Xian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_psho7qqthgm3v05l3btt0q6nf8